$AKESO(09926)$ view order deta

$AKESO(09926)$ view order details.@Trade Feed Decoder

09926

10-20 10:41

HKAKESO

Side	Price \| Filled	Realized P&L
Buy Open	118.80 1,000	-- Closed

AKESO

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
10-20
Trade Feed Decoder
The AKESO (09926) buy at 118.8 resulted in a -0.58% loss, suggesting potential challenges in entry timing or short-term volatility management. As a biotech stock, AKESO's price action often reacts sharply to clinical trial updates or regulatory news, requiring traders to align entries with catalyst timelines. The modest loss percentage indicates disciplined position sizing or early exit strategy, which could mitigate risk in this high-beta sector. However, biotech investments demand careful consideration of binary events – traders might evaluate whether this trade incorporated fundamental developments or technical patterns. The minimal drawdown demonstrates controlled risk exposure, though sector-specific risks like pipeline setbacks or funding cycles warrant ongoing monitoring for similar positions.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":491129991082064,"tweetId":"491129991082064","gmtCreate":1760928170304,"gmtModify":1762233260232,"author":{"id":3576836638991484,"idStr":"3576836638991484","authorId":3576836638991484,"authorIdStr":"3576836638991484","name":"eva111","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":160,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":110,"starInvestorOrderShareNum":377,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":9.55,"showRor":true,"winRationPercentage":51.485149,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/09926\">$AKESO(09926)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/09926\">$AKESO(09926)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$AKESO(09926)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":43,"commentSize":1,"repostSize":22,"favoriteSize":0,"link":"https://ttm.financial/post/491129991082064","repostId":0,"isVote":1,"tweetType":1,"viewCount":1391,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["09926"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3576836638991484","orderId":"40898232758572032","kind":"TRADE","symbol":"09926","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/09926\">$AKESO(09926)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/09926","symbolName":"AKESO","market":"HK","action":"BUY","currency":"HKD","symbolLogo":"https://static.tigerbbs.com/9839f6cd0b5650e6d52cfcbc3a7b2132","showFilledQuantity":true,"nameCN":"AKESO","orderType":"LMT","filledQuantityFinal":1000,"avgFillPrice":118.8,"createTime":1760928073,"filledQuantity":"1000","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"AKESO","contractExtraDescription":"09926","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":-0.0833},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":491149516985112,"commentId":"491149516985112","gmtCreate":1760932835041,"gmtModify":1760932839678,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":491129991082064,"objectIdStr":"491129991082064","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"The AKESO (09926) buy at 118.8 resulted in a -0.58% loss, suggesting potential challenges in entry timing or short-term volatility management. As a biotech stock, AKESO's price action often reacts sharply to clinical trial updates or regulatory news, requiring traders to align entries with catalyst timelines. The modest loss percentage indicates disciplined position sizing or early exit strategy, which could mitigate risk in this high-beta sector. However, biotech investments demand careful consideration of binary events – traders might evaluate whether this trade incorporated fundamental developments or technical patterns. The minimal drawdown demonstrates controlled risk exposure, though sector-specific risks like pipeline setbacks or funding cycles warrant ongoing monitoring for similar positions.","text":"The AKESO (09926) buy at 118.8 resulted in a -0.58% loss, suggesting potential challenges in entry timing or short-term volatility management. As a biotech stock, AKESO's price action often reacts sharply to clinical trial updates or regulatory news, requiring traders to align entries with catalyst timelines. The modest loss percentage indicates disciplined position sizing or early exit strategy, which could mitigate risk in this high-beta sector. However, biotech investments demand careful consideration of binary events – traders might evaluate whether this trade incorporated fundamental developments or technical patterns. The minimal drawdown demonstrates controlled risk exposure, though sector-specific risks like pipeline setbacks or funding cycles warrant ongoing monitoring for similar positions.","html":"The AKESO (09926) buy at 118.8 resulted in a -0.58% loss, suggesting potential challenges in entry timing or short-term volatility management. As a biotech stock, AKESO's price action often reacts sharply to clinical trial updates or regulatory news, requiring traders to align entries with catalyst timelines. The modest loss percentage indicates disciplined position sizing or early exit strategy, which could mitigate risk in this high-beta sector. However, biotech investments demand careful consideration of binary events – traders might evaluate whether this trade incorporated fundamental developments or technical patterns. The minimal drawdown demonstrates controlled risk exposure, though sector-specific risks like pipeline setbacks or funding cycles warrant ongoing monitoring for similar positions.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/491129991082064"}